Beloteca, Inc. Opens Product Development Laboratory In San Diego, California
10/28/2015
According to company officials, “Beloteca's primary focus is to develop and obtain regulatory approval for sterile pharmaceutical products with an emphasis on generics and 505(b)(2) reformulations. We target niche and difficult to manufacture products.”
"This new laboratory helps Beloteca achieve its mission of developing multiple products per year," said Fred Defesche, CEO of Beloteca, Inc. "It also allows Beloteca to take greater control over project timelines and the development process."
"The new laboratory establishes Beloteca's in-house product development capabilities allowing the evaluation of development projects prior to initiating full development creating a more nimble and aggressive approach to project selection. Additionally, the new laboratory will be used for many of Beloteca's analytical and formulation development activities enabling Beloteca to develop many of its products in house," stated Dorla Mirejovsky, CFO of Beloteca.
Project Announcements
Ninth Avenue Foods Plans Longview, Texas, Production Operations
12/06/2025
LayerZero Power Systems Expands Streetsboro, Ohio, Manufacturing Operations
12/06/2025
BioStem Technologies Plans Boca Raton, Florida, Headquarters Operations
12/06/2025
Saronic Technologies Expands St. Mary Parish, Louisiana, Operations
12/05/2025
JGA Space and Defense Expands Huntersville, North Carolina, Operations
12/05/2025
SODECIA-AAPICO Plans Orangeburg, South Carolina, Manufacturing Operations
12/05/2025
Most Read
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
First Person: Filter King’s Expansion Playbook
Q3 2025
-
Rethinking Auto Site Strategy in the Age of Tariffs and Powertrain Shifts
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
How Canada Stays Competitive
Q3 2025
-
America’s Aerospace Reboot
Q3 2025
-
The Permit Puzzle and the Path to Groundbreaking
Q3 2025